Rocket Lab's bounce has room to run to $65 after buyers returned following shipment of Neutron's second stage to its Virginia launch site. A break above $65 before November 9 results remains the real test. x.com 

Rocket Lab looks set for a major comeback as SpaceX, the main reason the space sector sold off, starts performing better. The same failed head-and-shoulders pattern that preceded Rocket Lab's parabolic 2024 run has formed again, with the stock bottoming exactly at the neckline, and SpaceX's improvement is already showing in other space stocks. x.com 

Rocket Lab could face a difficult 9-12 months because much of the space industry's future is already priced into equity valuations, even as its business and backlog grow. A monthly close below the $61 21-month EMA would raise the risk that the uptrend has ended and shift attention toward $35-45 for a better long-term entry; holding $61 preserves a more constructive reading. The company could still trade considerably higher over a longer horizon. x.com 

Rocket Lab should see money flow back once SpaceX's rich valuation corrects. SpaceX's listing day could be sell-the-news, pulling Rocket Lab back to $90-100 at most, but at roughly 90-100x sales it is valued about the same as SpaceX at around 115x. With expected Nasdaq inclusion on June 22 and capital rotating from SpaceX into quality space stocks, a lower-high move toward the $130 target banks just raised is possible. x.com  x.com 

Rocket Lab's growing Space Systems business positions it to provide more than launches for the space economy. It generated $189.5M in Q2, 81% of revenue; if its pending Iridium acquisition closes, it would gain a global satellite communications network. At about $51, this is one of the most compelling long-term opportunities in the space sector over 3-5 years, provided it keeps executing. Neutron's launch has slipped to 2027, and execution risks remain. x.com  x.com  x.com 

Rocket Lab still looks ridiculously expensive at 29 times forward sales against SpaceX at 22 times, even after a 65% fall. At 22 times, Rocket Lab would be roughly $38, and SpaceX would still be the pick. SpaceX also has better forward guidance; Rocket Lab's negative adjusted EBITDA makes sales multiples the valuation yardstick. x.com  x.com  x.com  x.com 

Rocket Lab targets $70 after bouncing nicely off the 0.618 Fibonacci level with a bullish daily RSI cross. Gamma and vanna exposure levels are acting as magnets and resistance for this week's expiry, and a small daily gap at $71.21-71.45 may get filled. x.com 

Rocket Lab is being disrespected given the pivotal role it should play in an exponentially growing rocket and space industry, even with SpaceX as the front-runner. The stock should get back above $100. x.com  x.com  x.com 

Rocket Lab's $3B at-the-market offering shows it needs investor cash because it has no real earnings or path to profitability, and it should have raised $10-15B while the window lasts. Selling stock at such a high valuation is the only way to sustain the next 18-24 months, and the coming SpaceX IPO will most likely be the sell event for the entire space sector. x.com  x.com 

Rocket Lab has legitimate buying behind it, visible in weekly volume, and could take out $100 this time, perhaps after a pullback, helped by the SpaceX IPO pump. Prior highs around $98-100 are the resistance to clear. x.com